表紙
市場調查報告書
商品編碼
956872

臨床微生物學用設備及試劑的全球市場

Clinical Microbiology Instruments and Reagents

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 664 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球臨床微生物學的市場規模在分析期間(2020年∼2027年)內預計將以6.4%的年複合成長率增長,到2027年達到61億美元。隨著COVID-19抗病毒藥物和疫苗的開發不斷發展,已在候選疫苗上投資了數十億美元,這迫使實驗室要擴大規模並充分發揮作用。

本報告提供全球臨床微生物學用設備及試劑市場的相關調查,提供市場佔有率,趨勢和預測,成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

I. 簡介,調查手法,調查範圍

II. 摘要整理

  • 市場概要
    • Covid-19的影響和即將到來的全球景氣衰退
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
  • 主要企業
  • 趨勢與成長要素
  • 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

IV. 競爭

  • 企業簡介:52公司
目錄
Product Code: MCP13302

Global Clinical Microbiology Instruments and Reagents Market to Reach $6.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Clinical Microbiology Instruments and Reagents estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$6.1 Billion by 2027, growing at aCAGR of 6.4% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 7.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 7.7% CAGR

The Clinical Microbiology Instruments and Reagents market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$305.3 Million by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Select Competitors (Total 59 Featured) -

  • 3M
  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Biomerieux
  • Bio-Rad Laboratories, Inc
  • Bruker Corporation
  • Cepheid Inc
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc
  • NEOGEN Corporation
  • QIAGEN GmbH
  • Hoff Man Roche - Diagnostics Division
  • Shimadzu Corporation
  • Thermo Fisher Scientific

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • EXHIBIT 1: The World of Clinical Microbiology Gains Sudden Prominence as Scientists Mobilize United Efforts to Find Ways to Detect, Treat & Vaccinate People Against the Novel Coronavirus: Global Scale of Daily Testing Vs Confirmed Cases Per Million
    • Clinical Microbiology: An Introduction
    • Outlook: Evolutionary Battle against Microbes Drives Market Future
    • Instant Detection of Pathogens : A New Epoch in the Fight for Survival
    • Reagents Account for Major Share
    • Asia-Pacific Drives Future Growth
    • Recent Market Activity
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Microbiology Laboratories Switch to Automation to Push Yields
    • EXHIBIT 2: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
    • Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
    • Integration of Clinical Microbiology with Cloud Computing
    • Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
    • Advancements in Molecular Diagnostics Drive Market Growth
    • Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis
    • Technological Advances Crucial to Sustain Future Market Growth
    • Rapid Diagnostics Bring in a Transformation
    • Automated and Rapid Microbiological Tests Revolutionize Microbiological Testing
    • Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
    • Antibiotic Resistant Bacteria Throws the Spotlight on Microbial Testing
    • Research in Stem Cell Technology, and Regenerative Medicine Expand Growth Opportunities
    • EXHIBIT 3: Stem Cell Banking Global Market Estimates and Forecasts in US$ Billion: 2020, 2022 & 2024
    • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
    • EXHIBIT 4: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
    • EXHIBIT 5: Number of AIDS-Related Deaths (in Thousands) by Region for 2018
    • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
    • Home HIV Testing Emerges as a Lucrative Option
    • Increasing Incidence of Infectious Diseases Drives Growth
    • EXHIBIT 6: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • EXHIBIT 7: Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Increasing Prevalence of Respiratory Infections Drive Growth
    • EXHIBIT 8: Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
    • Influenza Boosts Rapid Test Prospects
    • EXHIBIT 9: Flu Related CDC Estimates from October 2019-April4, 2020
    • Rise in Prevalence of COPD Augments Demand
    • EXHIBIT 10: Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition
    • Rise in Pollution Levels Trigger Increase in Respiratory Diseases
    • EXHIBIT 11: World Ranking of Most Polluted Countries: 2019
    • EXHIBIT 12: Percentage Share Breakdown of Global Deaths Linked to Air Pollution
    • Increase in Healthcare Spending in Emerging Markets to Propel Demand
    • EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Demographic Shifts & Societal Changes Drive Demand for Test Volumes
    • EXHIBIT 14: Elderly Healthcare Expenditure as a % of GDP
    • EXHIBIT 15: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 10: Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Clinical Microbiology Instruments and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Bloodstream Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Bloodstream Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Bloodstream Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Gastrointestinal Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Gastrointestinal Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Gastrointestinal Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Sexually Transmitted Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Sexually Transmitted Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Sexually Transmitted Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Urinary Tract Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Urinary Tract Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Urinary Tract Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other Disease Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other Disease Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Disease Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Custom Lab Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Custom Lab Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Custom Lab Service Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • Market Overview
    • EXHIBIT 16: Healthcare Spending as a % of GDP in the US: 2010-2020
    • COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests
    • TABLE 37: USA Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 43: USA Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: USA Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: USA 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 46: Canada Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Canada 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 52: Canada Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Canada Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Canada 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • JAPAN
    • Market Overview
    • Covid-19 Testing Market in Japan
    • Demographics Drive Market Growth
    • EXHIBIT 17: Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
    • Market Analytics
    • TABLE 55: Japan Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 58: Japan Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Japan Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Japan 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 61: Japan Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Japan Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Japan 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • CHINA
    • Market Overview
    • Covid-19 Testing Market
    • Market Analytics
    • TABLE 64: China Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 67: China Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: China Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: China 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 70: China Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: China Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: China 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Overview
    • COVID-19 Pandemic Propels Demand
    • Growth in Clinical Diagnostics Automation
    • Rise in Automated, and Rapid Tests in Clinical Applications
    • Ageing Demography: An Opportunity Indicator
    • Market Analytics
    • TABLE 73: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Clinical Microbiology Instruments and Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 82: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Europe Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 85: France Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 88: France Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: France Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: France 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 91: France Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: France Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: France 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 94: Germany Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 97: Germany Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Germany Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Germany 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 100: Germany Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Germany Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Germany 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 103: Italy Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 106: Italy Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Italy Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Italy 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 109: Italy Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Italy Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Italy 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 112: UK Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 115: UK Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: UK Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: UK 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 118: UK Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: UK Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: UK 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 121: Spain Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Spain Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Spain 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 124: Spain Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Spain Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Spain 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 127: Spain Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Spain Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Spain 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 130: Russia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Russia Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Russia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 133: Russia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Russia Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Russia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 136: Russia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Russia Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Russia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 139: Rest of Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 142: Rest of Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Rest of Europe Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Rest of Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 145: Rest of Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Rest of Europe Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Rest of Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Market Overview
    • Market Analytics
    • TABLE 148: Asia-Pacific Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Clinical Microbiology Instruments and Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Asia-Pacific Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Asia-Pacific 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 154: Asia-Pacific Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Asia-Pacific Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Asia-Pacific 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 157: Asia-Pacific Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Asia-Pacific Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Asia-Pacific 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 160: Australia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Australia Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Australia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 163: Australia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Australia Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Australia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 166: Australia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Australia Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: Australia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • INDIA
    • Market Overview
    • Private Enterprises Encourage Changes in Diagnostics Sector
    • Market Analytics
    • TABLE 169: India Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: India Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: India 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 172: India Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: India Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: India 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 175: India Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: India Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: India 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 178: South Korea Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: South Korea Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: South Korea 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 181: South Korea Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: South Korea Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: South Korea 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 184: South Korea Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: South Korea Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: South Korea 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Asia-Pacific Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 190: Rest of Asia-Pacific Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Rest of Asia-Pacific Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Rest of Asia-Pacific 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 193: Rest of Asia-Pacific Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Rest of Asia-Pacific Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Rest of Asia-Pacific 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • Market Overview
    • TABLE 196: Latin America Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Clinical Microbiology Instruments and Reagents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 199: Latin America Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Latin America Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Latin America 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 202: Latin America Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Latin America Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Latin America 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 205: Latin America Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Latin America Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Latin America 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 208: Argentina Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Argentina Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Argentina 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 211: Argentina Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Argentina Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Argentina 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 214: Argentina Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Argentina Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Argentina 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • BRAZIL
    • Market Overview
    • Market Analytics
    • TABLE 217: Brazil Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Brazil Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Brazil 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 220: Brazil Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Brazil Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Brazil 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 223: Brazil Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Brazil Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Brazil 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 226: Mexico Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Mexico Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Mexico 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 229: Mexico Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Mexico Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Mexico 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 232: Mexico Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Mexico Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Mexico 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 235: Rest of Latin America Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Rest of Latin America Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Rest of Latin America 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 238: Rest of Latin America Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Rest of Latin America Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Rest of Latin America 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 241: Rest of Latin America Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Rest of Latin America Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Rest of Latin America 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 244: Middle East Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Clinical Microbiology Instruments and Reagents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 247: Middle East Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Middle East Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Middle East 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 250: Middle East Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Middle East Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Middle East 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 253: Middle East Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Middle East Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Middle East 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 256: Iran Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Iran Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Iran 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 259: Iran Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Iran Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Iran 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 262: Iran Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Iran Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Iran 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 265: Israel Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Israel Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Israel 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 268: Israel Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Israel Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Israel 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 271: Israel Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Israel Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: Israel 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 274: Saudi Arabia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: Saudi Arabia Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: Saudi Arabia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 277: Saudi Arabia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: Saudi Arabia Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: Saudi Arabia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 280: Saudi Arabia Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: Saudi Arabia Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: Saudi Arabia 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 283: UAE Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: UAE Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: UAE 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 286: UAE Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: UAE Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: UAE 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 289: UAE Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: UAE Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: UAE 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 292: Rest of Middle East Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Rest of Middle East Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Rest of Middle East 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 295: Rest of Middle East Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Rest of Middle East Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Rest of Middle East 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 298: Rest of Middle East Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Rest of Middle East Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 300: Rest of Middle East 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027
  • AFRICA
    • South Africa
    • Market Analytics
    • TABLE 301: Africa Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 302: Africa Historic Review for Clinical Microbiology Instruments and Reagents by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 303: Africa 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 304: Africa Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 305: Africa Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area - Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 306: Africa 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area - Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027
    • TABLE 307: Africa Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 308: Africa Historic Review for Clinical Microbiology Instruments and Reagents by End-Use - Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 309: Africa 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 59